{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T19:47:01Z","timestamp":1778356021356,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.schres.2021.07.024","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:26:03Z","timestamp":1627604763000},"page":"102-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Predictors of clozapine discontinuation at 2\u202fyears in treatment-resistant schizophrenia"],"prefix":"10.1016","volume":"235","author":[{"given":"Barbara","family":"Iruretagoyena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen Paz","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Mena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Nachar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Pablo","family":"Ramirez-Mahaluf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Gonz\u00e1lez-Valderrama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Undurraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Maccabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas A.","family":"Crossley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2021.07.024_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.112506","article-title":"A systematic review of sex-based differences in effectiveness and adverse effects of clozapine","author":"Alberich","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2021.07.024_bb0010","doi-asserted-by":"crossref","DOI":"10.1111\/acps.12742","article-title":"International trends in clozapine use: a study in 17 countries","author":"Bachmann","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2021.07.024_bb0015","article-title":"Predictors of treatment-resistant and clozapine-resistant schizophrenia: a 12-year follow-up study of first-episode schizophrenia-Spectrum disorders","author":"Chan","year":"2020","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.07.024_bb0020","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-005-2174-x","article-title":"Predictors and markers of clozapine response","author":"Chung","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2021.07.024_bb0025","series-title":"Biological Psychiatry","article-title":"Management of treatment resistance in schizophrenia","author":"Conley","year":"2001"},{"key":"10.1016\/j.schres.2021.07.024_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.03.029","article-title":"Psychiatrists' attitude towards the use of clozapine in the treatment of refractory schizophrenia: a nationwide survey","author":"Daod","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2021.07.024_bb0035","doi-asserted-by":"crossref","DOI":"10.1198\/sbr.2011.10013","article-title":"Time to all-cause treatment discontinuation as the primary outcome in the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia study","author":"Davis","year":"2011","journal-title":"Stat. Biopharm. Res."},{"key":"10.1016\/j.schres.2021.07.024_bb0040","doi-asserted-by":"crossref","DOI":"10.1017\/S0033291717000435","article-title":"Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors","author":"Demjaha","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2021.07.024_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.psc.2007.04.001","article-title":"Treatment-resistant schizophrenia","author":"Elkis","year":"2007","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.schres.2021.07.024_bb0050","article-title":"The incidence of non-affective psychotic disorders in Chile between 2005 and 2018: results from a national register of over 30 000 cases","author":"Gonz\u00e1lez-Valderrama","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2021.07.024_bb0055","doi-asserted-by":"crossref","DOI":"10.1017\/S0033291721000246","article-title":"Demographic and clinical variables associated with response to clozapine in schizophrenia: a systematic review and meta-analysis","author":"Griffiths","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2021.07.024_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2014.10.048","article-title":"The effect of lifetime adversities on resistance to antipsychotic treatment in schizophrenia patients","author":"Hassan","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.07.024_bb0065","doi-asserted-by":"crossref","DOI":"10.1192\/bjp.bp.111.105833","article-title":"Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation","author":"Howes","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.07.024_bb0070","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.07.024_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/acps.13156","article-title":"Effect of age on the relative efficacy of clozapine in schizophrenia","author":"Jones","year":"2020","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2021.07.024_bb0085","doi-asserted-by":"crossref","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2021.07.024_bb0090","doi-asserted-by":"crossref","DOI":"10.1097\/YIC.0b013e32836508e6","article-title":"The social and economic burden of treatment-resistant schizophrenia: a systematic literature review","author":"Kennedy","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2021.07.024_bb0095","doi-asserted-by":"crossref","DOI":"10.1097\/JCP.0000000000000649","article-title":"Predictors of nonhospitalization and functional response in clozapine treatment: a nationwide, population-based cohort study","author":"K\u00f6hler-Forsberg","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2021.07.024_bb5000","article-title":"Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones","author":"Lasevoli","year":"2016","journal-title":"Prog Neuro-Psychopharmacology Biol Psychiatry"},{"key":"10.1016\/j.schres.2021.07.024_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(06)69875-9","article-title":"Health reform in Chile","author":"Letelier","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2021.07.024_bb0105","doi-asserted-by":"crossref","DOI":"10.1001\/archpsyc.62.9.975","article-title":"Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review","author":"Marshall","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2021.07.024_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/archpsyc.60.1.82","article-title":"Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT)","author":"Meltzer","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2021.07.024_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2018.02.056","article-title":"Early treatment resistance in a latin-american cohort of patients with schizophrenia","author":"Mena","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.07.024_bb0120","doi-asserted-by":"crossref","DOI":"10.1097\/YIC.0000000000000270","article-title":"Clozapine-associated neutropenia in Latin America: incidence report of 5380 chilean users","author":"Mena","year":"2019","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2021.07.024_bb0125","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.v68n1115","article-title":"The Texas medication algorithm project antipsychotic algorithm for schizophrenia: 2006 update","author":"Moore","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2021.07.024_bb0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.schres.2013.02.025","article-title":"Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades - a danish nationwide study from 1980 to 2010","volume":"146","author":"Nielsen","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.07.024_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2020.01.017","article-title":"Demographic and clinical features as predictors of clozapine response in patients with schizophrenia spectrum disorders: a systematic review and meta-analysis","author":"Okhuijsen-Pfeifer","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2021.07.024_bb0145","doi-asserted-by":"crossref","DOI":"10.1590\/1516-4446-2013-1190","article-title":"Is disorganized schizophrenia a predictor of treatment resistance? Evidence from an observational study","author":"Ortiz","year":"2013","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.schres.2021.07.024_bb0150","doi-asserted-by":"crossref","DOI":"10.1192\/bjp.bp.113.127753","article-title":"Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis","author":"Penttil\u00e4","year":"2014","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.07.024_bb0155","doi-asserted-by":"crossref","DOI":"10.1177\/0706743717720448","article-title":"Guidelines for the pharmacotherapy of schizophrenia in adults","author":"Remington","year":"2017","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.schres.2021.07.024_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2018.00327","article-title":"Biological predictors of clozapine response: a systematic review","author":"Samanaite","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.schres.2021.07.024_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2014.11.002","article-title":"A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders","author":"Sendt","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2021.07.024_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2018.06.070","article-title":"The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: a systematic review","author":"Shah","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2021.07.024_bb0175","doi-asserted-by":"crossref","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","author":"Siskind","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.07.024_bb0180","doi-asserted-by":"crossref","DOI":"10.1177\/0706743717718167","article-title":"Clozapine response rates among people with treatment-resistant schizophrenia: data from a systematic review and meta-analysis","author":"Siskind","year":"2017","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.schres.2021.07.024_bb0185","article-title":"Predictors of treatment resistant schizophrenia: a systematic review of prospective observational studies","author":"Smart","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2021.07.024_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2011.09.016","article-title":"Treatment resistant schizophrenia and response to antipsychotics: a review","author":"Suzuki","year":"2011","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2021.07.024_bb0195","first-page":"32","article-title":"Factors associated with response to clozapine in schizophrenia: a review","volume":"44","author":"Suzuki","year":"2011","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.schres.2021.07.024_bb0200","doi-asserted-by":"crossref","DOI":"10.1111\/acps.13208","article-title":"Adherence to clozapine vs. other antipsychotics in schizophrenia","author":"Takeuchi","year":"2020","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2021.07.024_bb0205","doi-asserted-by":"crossref","DOI":"10.1111\/acps.13208","article-title":"Adherence to clozapine vs. other antipsychotics in schizophrenia","author":"Takeuchi","year":"2020","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2021.07.024_bb0210","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ps.20110013","article-title":"Does assertive community outreach improve social support? Results from the Lambeth study of early-episode psychosis","author":"Tempier","year":"2012","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2021.07.024_bb0215","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.v63n0508","article-title":"Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia","author":"Umbricht","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2021.07.024_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2018.05.046","article-title":"Prescriber and institutional barriers and facilitators of clozapine use: a systematic review","author":"Verdoux","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.07.024_bb0225","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sby052","article-title":"Clozapine and long-term mortality risk in patients with schizophrenia: a systematic review and meta-analysis of studies lasting 1.1-12.5 years","author":"Vermeulen","year":"2019","journal-title":"Schizophr. Bull."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421002772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421002772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:43:28Z","timestamp":1760298208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996421002772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":44,"alternative-id":["S0920996421002772"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2021.07.024","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of clozapine discontinuation at 2\u202fyears in treatment-resistant schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2021.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}